Primary structure of human platelet factor 4

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Primary structure of human platelet factor 4

Abstract

References

A radioimmunoassay for platelet factor 4

Characterization of a chondroitin 4 -sulfate proteoglycan carrier for heparin neutralizing activity (platelet factor 4 ) released from human blood platelets

Prediction of protein conformation

Staphylococcal protease: a proteolytic enzyme specific for glutamoyl bonds

Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range

Release of platelet factor 4 by adenosine diphosphate and other platelet-aggregating agents

Reversible blocking of amino groups with citraconic anhydride

Platelet factor 4 and adenosine diphosphate release during human platelet aggregation

A protein sequenator

Nonenzymatic methods for the preferential and selective cleavage and modification of proteins

DISSOCIATION OF PLATELET ANTIHEPARIN FACTOR (PLATELET FACTOR 4) FROM LIPOPROTEIN LIPASE INHIBITOR

The relationship of heparin activity to platelet concentration

Citations

Negative regulation of human megakaryocytopoiesis by human platelet factor 4 (PF4) and connective tissue-activating peptide (CTAP-III)

Comparative studies of the interaction of human and bovine platelet factor 4 with heparin using histidine NMR resonances as spectroscopic probes

Isolation and identification of a 23,000-dalton heparin binding fragment from the amino terminus of bovine thrombospondin.

Improved radioimmunoassay of platelet factor 4 and beta-thromboglobulin in plasma

Platelet factor 4 binding to glomerular microvascular matrix

Interaction of platelet factor 4 with human platelets

Amino acid sequence homology between bovine and human platelet proteins

Importance of specific amino acids in protein binding sites for heparin and heparan sulfate

Carboxyterminal peptides with the dimeric form of PF4 retain the inhibitory effect on the growth of human megakaryoblastic cell lines

The 9E3/CEF4 gene and its product the chicken chemotactic and angiogenic factor (cCAF): potential roles in wound healing and tumor development

New prospects for chemokines

Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor

Negative regulation of human megakaryocytopoiesis by human platelet factor 4 and beta thromboglobulin: comparative analysis in bone marrow cultures from normal individuals and patients with essential thrombocythaemia and immune thrombocytopenic purpura

Synthesis of a novel cytokine and its gene (LD78) expressions in hematopoietic fresh tumor cells and cell lines

The role of platelet factor 4 in local and remote tissue damage in a mouse model of mesenteric ischemia/reperfusion injury

The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer

The chemokine system -- a major regulator of angiogenesis in health and disease

Neurochemokines: a menage a trois providing new insights on the functions of chemokines in the central nervous system

Release of platelet factor 4 into the blood after cold challenge of patients with cold urticaria

Platelet factor 4 antigen in megakaryocytes

Heparin-induced thrombocytopenia: diagnostic tests and biological mechanisms

Bovine platelet antiheparin protein: platelet factor 4

Systematic Review of the Neurobiological Relevance of Chemokines to Psychiatric Disorders

Platelets, complement and tissue inflammation

Human platelet factor 4 monomer-dimer-tetramer equilibria investigated by 1H NMR spectroscopy

Human platelet factor 4 subunit association/dissociation thermodynamics and kinetics

Chemistry, measurement, and clinical significance of platelet specific proteins

Ovine platelet factor 4: purification, amino acid sequence, radioimmunoassay and comparison with platelet factor 4 of other species

Improved method for purification of human platelet factor 4 by affinity and ion-exchange chromatography

Platelet factor 4 injection produces acute pulmonary hypertension in the awake lamb

Platelet factor 4 efficiently reverses heparin anticoagulation in the rat without adverse effects of heparin-protamine complexes

Isolation and partial characterization of platelet alpha-granule membranes

Platelets and Complement Cross-Talk in Early Atherogenesis

Platelet antiheparin proteins and antithrombin III interact with different binding sites on heparin molecule

Roles of platelet factor 4 in hematopoiesis and angiogenesis

Role of chemokines in endocrine autoimmune diseases

Editorial: History of Chemoattractant Research.

CCR5 -Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool

Research Trends and Regulation of CCL5 in Prostate Cancer.

Identification and characterization of PF4varl, a human gene variant of platelet factor 4.

Structure of the rat platelet factor 4 gene: a marker for megakaryocyte differentiation.

Human platelet basic protein. Its relation to low affinity platelet factor 4 and beta-thromboglobulin

X-ray diffraction analysis of crystals of bovine platelet factor 4

Isolation and amino acid sequence of bovine platelet factor 4

The marriage of chemokines and galectins as functional heterodimers.

C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection

Related Concepts

Related Feeds

Blood Clotting Disorders

Related Papers

Amino acid sequence of human platelet factor 4

Purification and characterization of human and bovine platelet factor 4

Complete covalent structure of human beta-thromboglobulin

Hierarchical self-assembly of surfactant-encapsulated and organically grafted polyoxometalate complexes

Bovine platelet antiheparin protein: platelet factor 4